Vasculitis doctor and researcher, father of three girls, diehard Celtics fan, musician
Joined January 2019
- Tweets 415
- Following 370
- Followers 1,871
- Likes 1,441
29 Photos and videos
Pinned Tweet
23 Feb 2025
I’m out of here. Will find different platforms to share research results. ✌️
15
1,628
Peter Grayson retweeted
13 Jun 2024
News: Skin manifestations in VEXAS syndrome are common and provide an important early clue to the diagnosis of this life-threatening disease.
Read the full NIAMS-led study via @JAMADerm 🔒. Abstract: jamanetwork.com/journals/jam…
ALT A graphic from the paper with illustrated depictions of ear or nose chondritis, urticarialike lesions, medium-vessel vasculitis, periorbital edema, neutrophilic dermatosis, and leukocytoclastic vasculitis on a person.
1
3
15
1,872
Peter Grayson retweeted
27 May 2024
A look back at the first workshop on #VEXAS syndrome! > 100 participants from 19 countries came in Paris. Thanks to the support of @contactfai2r. @TerrierBen @mekinian2 @petercgrayson @maferradastrong @KosmiderO @_ERNRITA @RimBourguiba1 @CiprianJurcut
3
20
46
7,686
24 May 2024
Many thanks to our French colleagues for hosting the first international VEXAS Congress in Paris. The only thing that was better than the science was the friendship. We had the best time with you! @SophieGeorgin @TerrierBen @mekinian2 @bhavishap29 @emmamgroarke @maferradastrong
4
5
63
3,087
Peter Grayson retweeted
20 Jan 2024
UBA1 somatic mutations of indeterminate potential? our provocative finding in @AllofUsResearch led by @rheumrob with @jamesfbrogan, @kwbyram & @petercgrayson
@VUMC_MedPSTP, @VUMCRheum @NIH_NIAMS
19 Jan 2024
Somatic mutations in UBA1 cause VEXAS, a severe inflammatory syndrome. For the first time, researchers have found 74 people with the mutation who don't have VEXAS. Studying them may give a peek into the earliest phases of disease.
In A&R
loom.ly/fZWodK4
@rheumrob
ALT Analysis of 245,368 diverse individuals in NIH All of Us Program finds incomplete penetrance of VEXAS-defining UBA1 p.Met41Leu somatic variant. Graphical abstract created with BioRender.com
3
11
55
9,475
20 Jan 2024
Population databases have shown very different findings related to VEXAS, reflecting selection bias. In AllofUs, 74 people with VEXAS mutations, 62 of them were female, 100% were p.Met41Leu, unclear if they have any disease phenotype. Terrific work led by @rheumrob !!!
19 Jan 2024
Somatic mutations in UBA1 cause VEXAS, a severe inflammatory syndrome. For the first time, researchers have found 74 people with the mutation who don't have VEXAS. Studying them may give a peek into the earliest phases of disease.
In A&R
loom.ly/fZWodK4
@rheumrob
ALT Analysis of 245,368 diverse individuals in NIH All of Us Program finds incomplete penetrance of VEXAS-defining UBA1 p.Met41Leu somatic variant. Graphical abstract created with BioRender.com
2
24
77
8,152
1 Dec 2023
Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasu’s arteritis, ANCA-associated vasculitis and giant cell arteritis ard.bmj.com/content/early/20…
New collaborative work from rheum and heme at NIH @fergutierrezro1 @bhavishap29 @KQuinnRheum @NealSYoung1
2
9
63
3,899
1 Dec 2023
We looked at CH prevalence in three forms of vasculitis that span the age spectrum.
Found that:
1. Age stronger driver of CH than vasculitis
2. Mostly small clones in DNMT3A and TET2
3. Association of clone size and relapse in GCA (unclear direction of association)
1
5
544
1 Dec 2023
Looks like CH is more a marker of inflammaging that primary driver of vasculitis - but may modify disease course
1
5
532
15 Nov 2023
#ACR23 need to find better way to incentivize attendance on the last half day of ACR Convergence. Turnout again pretty abysmal. Not fair to presenters of some very nice work today. End on full day or do something big at the very end.
14
10
118
15,404
Peter Grayson retweeted
13 Nov 2023
Everyone at #ACR23 be sure and tune in to @AtefehGho’s talk this Wed showcasing our @nih_nhlbi @MayoClinic @NIH_NIAMS collaboration reporting on the high rates of thrombosis (mainly #VTE) seen in our #VEXAS cohort. acr23.eventscribe.net/search…
5
24
2,162
15 Nov 2023
First ever non-HLA germline genetic association identified in RP. Masters thesis work from Yiming Luo from our group at NIH. @RP_Organization @maferradastrong
Ultra-rare genetic variation in relapsing polychondritis: a whole-exome sequencing study ard.bmj.com/content/early/20…
13
48
8,985
Peter Grayson retweeted
13 Nov 2023
#ACR23 check out @rheumrob's late breaking poster tomorrow - he has identified individuals with somatic UBA1 mutations who are resilient to VEXAS cdmcd.co/vabX8j
Full details in his preprint: medrxiv.org/content/10.1101/… @ACRheum @VUMCRheum @VUMC_MedPSTP
1
13
48
5,350
Peter Grayson retweeted
11 Nov 2023
@maferradastrong is an inspiration.
She was driven to improve outcomes for relapsing polychondritis, the disease she lives with, & now she leads her field.
Truly the model of a patient-physician, always so much to learn from her.
#ACR23 Review Course @RheumNow @Polychondritis
7
23
2,573
4 Oct 2023
Family talking this morning about the “speaker of the house” being removed. Five year old looked concerned and nervously asked, “Alexa?” 🤣🤣🤣
1
27
1,813
Peter Grayson retweeted
22 Sep 2023
👆🏼#VEXAS syndrome is believed to only affect individuals above the age of 50.
😮We describe an early-onset case in a 23 y/o 🙎🏽♂️ with relapsing polychondritis.
🗝️Test for UBA1 mutations🧬, regardless of age, in adults with a VEXAS clinical phenotype.
@ivette_pataki @RheumJnl
12
55
197
28,682
9 Sep 2023
@EcemSevimMD from NIAMS Rheumatology Fellowship Training Program speaking about micro vascular disease at Society Vascular Medicine Conference @YogenKanthi
2
1
10
1,132
13 Jul 2023
Best part of the VEXAS project from the science perspective is the collaborations! Rheum Heme is an amazing confluence of interests.
13 Jul 2023
Excited to share our work on CH in #VEXAS syndrome in collaboration with amazing colleagues at @MayoClinic
Full article - authors.elsevier.com/a/1hPeT…
@nih_nhlbi
@fergutierrezro1 @MrinalPatnaik @petercgrayson @NealSYoung1
8
42
4,466